STENO Stock Overview
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Stenocare A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.3.47 |
| 52 Week High | kr.11.00 |
| 52 Week Low | kr.2.94 |
| Beta | 0.040 |
| 1 Month Change | 0.29% |
| 3 Month Change | -23.57% |
| 1 Year Change | -63.78% |
| 3 Year Change | -78.31% |
| 5 Year Change | n/a |
| Change since IPO | -90.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| STENO | DK Pharmaceuticals | DK Market | |
|---|---|---|---|
| 7D | -1.1% | 0.4% | -0.6% |
| 1Y | -63.8% | 18.9% | 32.2% |
Return vs Industry: STENO underperformed the Danish Pharmaceuticals industry which returned 18.9% over the past year.
Return vs Market: STENO underperformed the Danish Market which returned 32.2% over the past year.
Price Volatility
| STENO volatility | |
|---|---|
| STENO Average Weekly Movement | 6.5% |
| Pharmaceuticals Industry Average Movement | 4.9% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in DK Market | 9.4% |
| 10% least volatile stocks in DK Market | 2.5% |
Stable Share Price: STENO is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: STENO's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Danish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | Thomas Schnegelsberg | https://stenocare.dk |
Stenocare A/S cultivates, produces, imports, sells, and distributes prescription-based medical cannabis products in the Danish and European markets. It offers medical cannabis oil products. Stenocare A/S was incorporated in 2017 and is based in Randers, Denmark.
Stenocare A/S Fundamentals Summary
| STENO fundamental statistics | |
|---|---|
| Market Cap | kr.52.00m |
| Earnings (TTM) | -kr.15.91m |
| Revenue (TTM) | kr.5.67m |
9.1x
P/S Ratio-3.2x
P/E RatioIs STENO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STENO income statement (TTM) | |
|---|---|
| Revenue | kr.5.67m |
| Cost of Revenue | kr.10.60m |
| Gross Profit | -kr.4.93m |
| Other Expenses | kr.10.98m |
| Earnings | -kr.15.91m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.07 |
| Gross Margin | -86.88% |
| Net Profit Margin | -280.62% |
| Debt/Equity Ratio | 26.2% |
How did STENO perform over the long term?
See historical performance and comparison